Details for New Drug Application (NDA): 012940
✉ Email this page to a colleague
NDA 012940 describes ISORDIL, which is a drug marketed by Wyeth Ayerst, Bausch, and Biovail, and is included in three NDAs. It is available from one supplier. Additional details are available on the ISORDIL profile page.
The generic ingredient in ISORDIL is isosorbide dinitrate. There is one drug master file entry for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the isosorbide dinitrate profile page.
The generic ingredient in ISORDIL is isosorbide dinitrate. There is one drug master file entry for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the isosorbide dinitrate profile page.
Summary for 012940
| Tradename: | ISORDIL |
| Applicant: | Biovail |
| Ingredient: | isosorbide dinitrate |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 012940
Profile for product number 003
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;SUBLINGUAL | Strength | 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Jul 29, 1988 | TE: | RLD: | Yes | |||||
Profile for product number 004
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;SUBLINGUAL | Strength | 2.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Jul 29, 1988 | TE: | RLD: | Yes | |||||
Profile for product number 005
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;SUBLINGUAL | Strength | 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Jul 29, 1988 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
